The effect of Nevazin and vitamin B1 in treatment of chemotherapy-induced neuropathy

Phase 3

Recruiting

• Conditions: Condition 1: neuropathy. Condition 2: chemotherapy.; Drug-induced polyneuropathy; Encounter for antineoplastic chemotherapy; G62.0; Z51.11

• Registration Number: IRCT20230722058878N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

All cancer patients who are undergoing chemotherapy

Exclusion Criteria

People who are allergic to medicines containing vitamin B
use of other drugs effective in improving neuropathy such as Gabapentin, Pregavalin, Duloxetine

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of neuropathy after chemotherapy. Timepoint: Before and after treatment. Method of measurement: Valk questionnaire.